Mitsuru Yamamoto
事業開発 @ Shionogi & Co., Ltd
About
Thank you for visiting my profile. My name is Mitsuru Yamamoto, Business Development at Shionogi Co., Ltd.,\ and Global Innovation Team at Shionogi B.V based in Amsterdam. I joined Shionogi as CMC API chemist in 2006. after working as CMC API process chemist for 8 years, I transfered to Business development department in 2014 and I have almost 9 years experiences for BD to deal with various type of opportunities as project leader and 2 years for Global Innovation to scout early stage opportunities and make alliances with global life science ecosystems such as academic society, Incubator, Biocluster and VCs. As for recent work, I was project manager for BD projects in the following collaboration to conduct negotiation/alliance manager with current collaborators. https://www.shionogi.com/global/en/news/2023/3/e20230329.html https://www.shionogi.com/global/en/news/2022/2/e20220210.html https://www.kotai-bio.com/jp/news/post-1290/ https://www.shionogi.com/global/en/news/2021/04/e-210428.html https://www.shionogi.com/global/en/news/2020/11/e-201116.html In addition to this, I have also experiences on in-license/out-license deals on clinical assets such as the followings regardless of modality, disease area, deal type (not only simple license but also investment, Joint Venture and M&A) https://www.shionogi.com/content/dam/shionogi/seu/news/pdf/2016/e160229-roche-188.pdf https://www.shionogi.com/content/dam/shionogi/global/news/pdf/2017/e171031.pdf https://www.shionogi.com/content/dam/shionogi/global/news/pdf/2018/e_180614.pdf https://www.shionogi.com/content/dam/shionogi/global/news/pdf/2018/e_181206.pdf
Japan
Osaka
Pharmaceuticals
Due Diligence, VC, プロジェクトマネジメント, Global innovation, 企業価値評価, 製薬業界分析, M&Aデューデリジェンス, グローバルアライアンス, コーポレートベンチャーキャピタル, 契約交渉, オープンイノベーション, ベンチャーキャピタル, 事業開発, 医薬, デューデリジェンス, M&A, 合弁事業, 投資戦略, 事業戦略, 知的財産
Experience

Business Development Representative
日本 大阪府
I transfered to Business development department in 2014 and I have almost 8 years experiences for BD. I was in charge of management Due diligence team, business/scientific evaluation on various disease area such as infectious disease, CNS, metabolic disease and oncology from 2014 to 2018, and then, from 2019 to now, I belong to open innovation group to deal with early stage assets/deals on technologies. As for recent work, I'm project manager in the following collaboration to conduct negotiation/alliance manager with current collaborators. https://www.kotai-bio.com/jp/news/post-1290/ https://www.shionogi.com/jp/ja/news/2021/04/210428.html https://www.shionogi.com/jp/ja/news/2020/11/201116.html https://www.shionogi.com/jp/ja/news/2020/11/201125.html In addition to this, I have also experiences on in-license/out-license deals on clinical assets such as the followings regardless of modarity, disease area, deal type (not only simple license but also investment, Joint Venture and M&A) https://www.shionogi.com/jp/ja/news/2016/02/160229-2.html https://www.shionogi.com/content/dam/shionogi/jp/news/pdf/2017/171031_1.pdf https://www.shionogi.com/jp/ja/news/2018/06/180614.html https://www.shionogi.com/jp/ja/news/2018/12/181206.html
Mitsuru Yamamoto's Contact Information
Phone
Find the Right Leads
Find Verified Contact Data
What LeadContact does well
Find verified emails, phone numbers, and decision-makers with 98% accuracy.
Find Leads
Find the right people by company, role, industry, location, and more.
925M+ professional profiles

Find Emails
Access verified email addresses for your target contacts.
657M+ emails

Find Phone Numbers
Get cross-validated phone data from multiple top sources.
239M+ phone numbers

More Accurate. Lower Cost.
Find contact data in 1 tool with 98% accuracy
LeadContact integrates leading enrichment tools to deliver more accurate contact data—without paying for each one.
Great conversations start with the right contact.
It’s time to find yours.



